Skip to content

/ La Crosse Method Protocol

La Crosse Method Protocol

3 Populations Allergy Drops Reach That Allergy Shots Do Not

July 24, 2019

One of the most important hallmarks of the La Crosse Method™ Protocol is the custom, patient-tailored approach to treating allergy. Each sublingual immunotherapy (SLIT) prescription is created based on specific test results, exam and patient history. No two patients are the same, and neither are the allergy drops following this protocol. Because of this personalized…

Read More

The Hidden Costs of Allergy to Employers: How to Crack the Code

July 10, 2019

When looking at the top healthcare costs impacting employers today, allergy is typically not top of mind. Cancer, diabetes, heart disease and musculoskeletal issues usually receive top billing, and are often easier to identify in employee groups. Allergy, on the other hand, is commonly hidden under related conditions and co-morbidities, making it difficult for organizations…

Read More

Back to the Basics: Treating Mold Allergy with Allergy Drops

June 26, 2019

For the past few months, news coverage has focused on flooding, first in the South, making its way to the Midwest. From an allergy perspective, we know this typically means mold, and lots of it. Are you starting to feel the sting of mold allergy? Symptoms of mold allergy can range widely, and can appear…

Read More

20 Billion Reasons to Start Treating the Cause of Allergies

June 11, 2019

And no, that’s not an exaggeration. The top 200 medications, in terms of retail sales, were recently released for 2018. While the medications on this list treat a wide variety of conditions – from diabetes to cystic fibrosis – allergy made a not-so-surprising appearance on the list. Nine of the medications on the list, totaling…

Read More

Top 3 Characteristics to Look for in an Allergist

September 19, 2018

Dr. George Kroker is a partner at Allergy Associates of La Crosse, a co-author of the La Crosse Method™ Protocol, and has been practicing allergy for 38 years. During his time as an allergist, he’s not only helped thousands of people overcome their allergies, but has done so while practicing kindness and compassion along the…

Read More

In Praise of Pioneers: In Memoriam – David L. Morris MD, 1929-2017

February 8, 2017

My husband grew up highly allergic. Spending time on his grandparent’s farm, a visit to the chicken coop would send him into a tailspin. An accidental brush with a horsehair blanket resulted in head-to-toe hives, wheezing and a quick visit to the local ER. Years of shots, inhalers, Tedral and other various prescription and over-the-counter…

Read More

Epinephrine and education: Perspectives using the La Crosse Method

January 25, 2017

With the recent controversy over skyrocketing EpiPen prices, more patients and providers are scrutinizing when — or whether — the life-saving epinephrine device is needed for use with sublingual immunotherapy using the La Crosse Method Protocol. In the experience of the La Crosse Method Protocol authors, the safety of sublingual immunotherapy following the La Crosse…

Read More

The Total Allergen Load: An Explanation for Spontaneous Allergies

June 29, 2016

When I recently asked Dr. George Kroker, an allergist with Allergy Associates of La Crosse, about the importance of the phenomenon called the Total Allergen Load, he responded with, “Never have so few words had such a great impact on my day-to-day practice.” Dr. Kroker further explained the concept with a patient who was confused…

Read More

Three is the Key to Development of Allergic Tolerance

October 7, 2015

Three is the key…this number holds a lot of importance in what believe makes the La Crosse Method™ Protocol safe and effective long term. First, three times a day. Every day. That’s been our daily mantra for dosing with allergy drops for decades. Many patients and providers ask why three times a day versus just…

Read More

La Crosse Method Reviewed

August 25, 2015

In recent years, sublingual immunotherapy has continued to gain acceptance and understanding, leading to its international recognition as a viable alternative to subcutaneous injection for allergy in both adults and children.1 With the recent FDA approval of single antigen sublingual immunotherapy tablets, even more physicians are considering, referring or offering sublingual immunotherapy for their patients.…

Read More